Literature DB >> 26797370

Correlation Between the Reduction in Lenticulostriate Arteries Caused by Hypertension and Changes in Brain Metabolism Detected With MRI.

Yuan-chang Chen1, Yue-hua Li1, Jing Lu1, Wen-bin Li1, Jian-bo Wang1.   

Abstract

OBJECTIVE: Hypertension can alter the vascular structure, mechanics, and function of small arteries and arterioles. It remains unknown whether microvascular changes are associated with brain metabolism. The purpose of this study was to analyze the correlation between the reduction in small arteries and changes in brain metabolism in patients with hypertension. SUBJECTS AND METHODS: The study population comprised 50 patients with hypertension and 50 volunteers without hypertension. The two groups underwent 3-T 3D time-of-flight MR angiography, and the numbers of lenticulostriate arteries (LSAs) were determined for both groups. Single-voxel proton MR spectroscopic data on the basal ganglia regions were also acquired. The ratios of N-acetylaspartate to creatine (NAA/Cr), myo-inositol to creatine (Mi/Cr), and choline to creatine (Cho/Cr) were measured. Statistical analysis was performed to evaluate the differences between the two groups with respect to metabolite ratios.
RESULTS: The average total number of LSA stems on both sides in patients with hypertension was 5.12 ± 0.98 compared with 6.10 ± 0.95 in volunteers without hypertension (p < 0.0001). The NAA/Cr ratio decreased according to a reduction in the number of LSAs in the hypertension group, which was significantly reduced when the number of LSAs was 3 or fewer.
CONCLUSION: Hypertension can lead to a statistically significant reduction in NAA/Cr ratio in the basal ganglia regions when the number of LSAs decreases to a certain extent. Reduced numbers of LSAs correlated with brain metabolism changes caused by hypertension, which can provide important insights for understanding the pathophysiologic mechanism of hypertension and may be valuable in evaluating this disease.

Entities:  

Keywords:  MR angiography; MR spectroscopy; brain metabolism; hypertension; lenticulostriate arteries

Mesh:

Year:  2016        PMID: 26797370     DOI: 10.2214/AJR.15.14514

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Visualization of the lenticulostriate arteries at 3T using black-blood T1-weighted intracranial vessel wall imaging: comparison with 7T TOF-MRA.

Authors:  Zihao Zhang; Zhaoyang Fan; Qingle Kong; Jiayu Xiao; Fang Wu; Jing An; Qi Yang; Debiao Li; Yan Zhuo
Journal:  Eur Radiol       Date:  2018-08-27       Impact factor: 5.315

2.  Imaging features of adult moyamoya disease patients with anterior intracerebral hemorrhage based on high-resolution magnetic resonance imaging.

Authors:  Jiali Xu; Gary B Rajah; Houdi Zhang; Cong Han; Xuxuan Shen; Bin Li; Zhengxing Zou; Wenbo Zhao; Changhong Ren; Guiyou Liu; Yuchuan Ding; Qi Yang; Sijie Li; Xunming Ji
Journal:  J Cereb Blood Flow Metab       Date:  2022-06-29       Impact factor: 6.960

3.  MRI-guided thrombolysis for lenticulostriate artery stroke within 12 h of symptom onset.

Authors:  Jianying Zhang; Qingke Bai; Zhenguo Zhao; Yiting Mao; Qiang Dong; Wenjie Cao
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

4.  Sensitivity of three-dimensional time-of-flight 3.0 ​T magnetic resonance angiography in visualizing the number and course of lenticulostriate arteries in patients with insular gliomas.

Authors:  Andrey E Bykanov; David I Pitskhelauri; Artem I Batalov; Robert Young; Maxim A Trube; Andrei I Holodny; Igor N Pronin; Timur Zagidullin
Journal:  Brain Spine       Date:  2021-12-21

5.  Characterization of Lenticulostriate Arteries and Its Associations With Vascular Risk Factors in Community-Dwelling Elderly.

Authors:  Xiaopei Xu; Xiao Wu; Chengcheng Zhu; Ruiting Zhang; Yeerfan Jiaerken; Shuyue Wang; Hui Hong; Wenke Yu; Kaicheng Li; Qingze Zeng; Xiao Luo; Xinfeng Yu; Jianzhong Sun; Minming Zhang; Peiyu Huang
Journal:  Front Aging Neurosci       Date:  2021-06-22       Impact factor: 5.702

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.